Hyloris Pharmaceuticals SA (LON:0AB6)

Hyloris Pharmaceuticals Statistics

Total Valuation

LON:0AB6 has a market cap or net worth of GBP 178.55 million. The enterprise value is 163.33 million.

Market Cap	178.55M
Enterprise Value	163.33M

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	28.00M
Shares Outstanding	n/a
Shares Change (YoY)	-4.61%
Shares Change (QoQ)	+1.44%
Owned by Insiders (%)	58.91%
Owned by Institutions (%)	0.02%
Float	11.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.62
PB Ratio	7.21
P/TBV Ratio	8.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.72
EV / Sales	22.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.62

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.06.

Current Ratio	3.82
Quick Ratio	3.76
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.24
Interest Coverage	-9.92

Financial Efficiency

Return on equity (ROE) is -20.18% and return on invested capital (ROIC) is -11.11%.

Return on Equity (ROE)	-20.18%
Return on Assets (ROA)	-9.03%
Return on Invested Capital (ROIC)	-11.11%
Return on Capital Employed (ROCE)	-19.40%
Weighted Average Cost of Capital (WACC)	6.66%
Revenue Per Employee	145,020
Profits Per Employee	-109,926
Employee Count	50
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-138,865
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.84% in the last 52 weeks. The beta is 0.41, so LON:0AB6's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+35.84%
50-Day Moving Average	6.79
200-Day Moving Average	7.51
Relative Strength Index (RSI)	54.49
Average Volume (20 Days)	367

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0AB6 had revenue of GBP 7.25 million and -5.50 million in losses. Loss per share was -0.21.

Revenue	7.25M
Gross Profit	7.04M
Operating Income	-5.11M
Pretax Income	-5.64M
Net Income	-5.50M
EBITDA	-4.98M
EBIT	-5.11M
Loss Per Share	-0.21

Balance Sheet

The company has 16.39 million in cash and 1.41 million in debt, with a net cash position of 14.98 million.

Cash & Cash Equivalents	16.39M
Total Debt	1.41M
Net Cash	14.98M
Net Cash Per Share	n/a
Equity (Book Value)	24.76M
Book Value Per Share	0.91
Working Capital	15.31M

Cash Flow

In the last 12 months, operating cash flow was -5.91 million and capital expenditures -6,000, giving a free cash flow of -5.91 million.

Operating Cash Flow	-5.91M
Capital Expenditures	-6,000
Free Cash Flow	-5.91M
FCF Per Share	n/a

Margins

Gross margin is 97.08%, with operating and profit margins of -70.47% and -75.80%.

Gross Margin	97.08%
Operating Margin	-70.47%
Pretax Margin	-77.72%
Profit Margin	-75.80%
EBITDA Margin	-68.66%
EBIT Margin	-70.47%
FCF Margin	n/a

Dividends & Yields

LON:0AB6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.61%
Shareholder Yield	4.61%
Earnings Yield	-3.08%
FCF Yield	-3.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0AB6 has an Altman Z-Score of 9.84.

Altman Z-Score	9.84
Piotroski F-Score	n/a